Press releases

Release
12.11.2018

VALBIOTIS announces expansion of application for VALEDIA to include NASH prevention

Download
Release
06.11.2018

VALBIOTIS confirms the publication of the results from international Phase IIA clinical study evaluating VALEDIA® for the risk reduction of type 2 diabetes, by mid-2019

Download
Release
30.10.2018

VALBIOTIS signs scientific partnership with CarMeN, biomedical research laboratory in the field of metabolic diseases

Download
Release
17.10.2018

VALBIOTIS confirms its interest in the study of the intestinal microbiota

Download
Release
08.10.2018

Appointment of Murielle CAZAUBIEL as Head of Development and Medical Affairs

Download
Release
05.10.2018

Strengthening of the liquidity contract (in French)

Download
Release
03.10.2018

VALEDIA®: Key data supporting the submission of a health claim

Download
Release
02.10.2018

Successful capital increase by private placement of € 2.3M (in French)

Download
Release
01.10.2018

Launching a capital increase by private investment (in French)

Download